Cecilia Lee, MD, is a clinician-scientist whose research integrates retinal imaging, clinical epidemiology, and big data to study the eye as a biomarker of systemic and neurodegenerative diseases. She leads NIH-funded longitudinal studies, including Eye ACT, and serves as Program Director for the AI-READI project under the NIH Bridge2AI initiative. Her work focuses on population-based research, AI-driven analysis, and the development of non-invasive retinal biomarkers to advance early detection, prevention, and precision health in aging and chronic conditions such as Alzheimer’s disease and diabetes.